Frazier Life Sciences Management, L.P.

Q1 2022 13F Holdings Report, Stock Holdings

Signature - Title
Steve R. Bailey - Chief Financial Officer and Chief Compliance Officer
Location
Palo Alto, CA
Holdings as of
31 Mar 2022
Value $
$1.17B
Num holdings
42
Filing time
13 May 2022, 19:15:51 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ARQT, PHAT, MIRM, SRRA, and KRYS.
Next filing
Q2 2022 - 10 Aug 2022
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Steve R. Bailey Chief Financial Officer and Chief Compliance Officer Menlo Park, California 13 May 2022